First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview. Johnston J, So T-Y Drugs. 2012 Jun 18; 72(9):1195-211. PMID: 22642799. Abstract CommentRecommendBookmarkWatch